일본 항암제, CNS 치료제, 미국시장서 높은 허가가능성 보여 (Korean-language podcast)

Citeline Podcasts
03/08/2023 4 min
일본 항암제, CNS 치료제, 미국시장서 높은 허가가능성 보여 (Korean-language podcast)

Listen "일본 항암제, CNS 치료제, 미국시장서 높은 허가가능성 보여 (Korean-language podcast)"

Descargar episodio Ver en sitio original

Episode Synopsis

Citeline의 최신 연구보고서에 따르면 미국시장에서 대형 일본제약사들의 항암제, CNS 치료제 허가가능성이 상대적으로 높은 것으로 나타났다. 어떤 요인이 작용했을까? (Scrip 기사를 요약한 내용입니다)

https://scrip.pharmaintelligence.informa.com/SC148677/Whats-Behind-Japan-Firms-Higher-Approval-Rates-In-Challenging-Oncology-CNS-Areas

More episodes of the podcast Citeline Podcasts

Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 10/11/2025
Scrip's Five Must-Know Things - Nov. 10, 2025 10/11/2025
Drug Fix: Examining George Tidmarsh’s Departure As Head Of US FDA’s Drug Center 07/11/2025
Podcast: Beyond The Checkpoint — Next-Gen Strategies In Immuno-Oncology 06/11/2025
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast) 04/11/2025
Scrip's Five Must-Know Things - Nov. 4, 2025 04/11/2025
Drug Fix: US FDA Streamlines Biosimilar Development Requirements, Clarifies Inspection Reform 31/10/2025
Decoding Cell Differentiation: How AI Foundation Models Are Reshaping Regenerative Medicine 31/10/2025
Scrip M&A Podcast: What's Next For Dealmaking In The Obesity Space? 31/10/2025
국내 바이오텍 펀딩 활성화를 위해 새로운 촉매제 필요 (Korean-language podcast) 31/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA